“IO+IO”,也就是免疫肿瘤学(immuno-oncology)+介入肿瘤学(interventional oncology),或可产生 “IO的平方”的治疗效果。这似乎是较难实现的目标,但目前确实取得了一些进展。基于中国原发性肝癌诊疗指南,在CNLC IIIa期HCC的治疗中,推荐TACE联合系...
12. Pascale Tomasini, et al. Precision Immuno-Oncology for advanced Non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors Resistance (PIONeeR): a phase Ib/IIa clinical trial targeting identified resistance ...
编者按:2024年欧洲肿瘤内科学会(ESMO)年会将于9月13日～17日在西班牙巴塞罗那召开。目前,ESMO官网已公布报告标题及壁报标题,《肿瘤瞭望》特将肺癌部分的口头报告进行汇总,如有缺漏和错误,欢迎留言指正。 主席论坛(Presidential Symposium) 摘要号:LBA8 英文标题:Precision Immuno-Oncology for advanced Non-small cell l...
编者按:2024年欧洲肿瘤内科学会(ESMO)年会将于9月13日～17日在西班牙巴塞罗那召开。目前,ESMO官网已公布报告标题及壁报标题,《肿瘤瞭望》特将肺癌部分的口头报告进行汇总,如有缺漏和错误,欢迎留言指正。 主席论坛(Presidential Symposium) 摘要号:LBA8 英文标题:Precision Immuno-Oncology for advanced Non-small...
Precision Immuno-Oncology for advanced Non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors Resistance (PIONeeR): a phase Ib/IIa clinical trial targeting identified resistance pathways PD-(L)1抑制剂耐药的晚期NSCLC患者的精确免疫肿瘤学:一项针对已识别耐药通路的Ib/IIa期PIONeeR临床试验 ...
标题:Precision Immuno-Oncology for advanced Non-small cell lung cancer (NSCLC) patients with PD-(L)1 inhibitors Resistance (PIONeeR): a phase Ib/IIa clinical trial targeting identified resistance pathways 讲者:Pascale Tomasini (Marseille, France, Cedex) ...
2024年欧洲肿瘤内科学会(ESMO)年会将于9月13日～17日在西班牙巴塞罗那召开。目前,ESMO官网已公布报告标题及壁报标题,《肿瘤瞭望》特将肺癌部分的口头报告进行汇总,如有缺漏和错误,欢迎留言指正。 主席论坛(Presidential Symposium) 摘要号:LBA8 英文标题:Precision Immuno-Oncology for advanced Non-small cell lung can...
(ESCC), benefiting about 80,000 patients. Meanwhile, HANSIZHUANG’s Marketing Authorisation Application (MAA) for ES-SCLC has been validated by the European Medicines Agency (EMA), which is expected to be approved in 2024. Moreover, a wide variety of clinical trials on immuno-oncology ...
Date: 10-12 December 2024 Venue: London, United Kingdom Organized by: European Society for Medical Oncology Save the date for the ESMO Immuno-Oncology Congress 2025, taking place from 10 until 12 December 2025 as an onsite event in London, UK, as well as online. ...
Date: 10-12 December 2024 Venue: London, United Kingdom Organized by: European Society for Medical Oncology Save the date for the ESMO Immuno-Oncology Congress 2025, taking place from 10 until 12 December 2025 as an onsite event in London, UK, as well as online. ...